Dynavax (DVAX) Tops Q3 EPS by 5c
Tweet
Share
E-mailGet Alerts DVAX Hot Sheet
Price: $15.50 --0%
Financial Fact:
Basic and diluted net loss per share: -0.9
Today's EPS Names:
CRMT, FOMI, FLES, More
Financial Fact:
Basic and diluted net loss per share: -0.9
Today's EPS Names:
CRMT, FOMI, FLES, More
Join SI Premium – FREE
Dynavax (NASDAQ: DVAX) reported Q3 EPS of ($0.70), $0.05 better than the analyst estimate of ($0.75). Revenue for the quarter came in at $685 thousand versus the consensus estimate of $1.15 million.
For earnings history and earnings-related data on Dynavax (DVAX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Trump discloses over $1.4 billion in crypto income in 2025 filing
- GNI Group acquires Ayumi Pharmaceutical for ¥44.8 billion
- Netflix gains over 3% as report refutes NBCUniversal acquisition speculation
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
